908 Devices (MASS) Deferred Taxes (2023 - 2024)
908 Devices' (MASS) quarterly Deferred Taxes came in at -$73000.0 in Q4 2024, down 10.61% year-on-year from -$81661.0 in Q1 2024, and down 1.39% on a QoQ basis from -$72000.0 in Q3 2024.
908 Devices (MASS) Deferred Taxes (2023 - 2024) Analysis & Trends
908 Devices (MASS) has 2 years of Deferred Taxes data on file, last reported at -$73000.0 in Q4 2024.
- On a quarterly basis, Deferred Taxes fell 10.61% year-over-year to -$73000.0 in Q4 2024; TTM through Dec 2024 was -$283000.0, a 7.21% increase from a year earlier, with the FY2024 full-year figure at -$283000.0, up 7.21% from the prior year.
- Deferred Taxes for Q4 2024 stood at -$73000.0, down from -$72000.0 in the prior quarter.
- Over the last five years, Deferred Taxes for MASS reached as high as -$50000.0 in Q1 2023 and fell as low as -$117000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 7.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 51.51 Mn |
| 10 | 908 Devices | 264.17 Mn | 152.43 Mn | 6.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -73,000.00 |
| Sep 30, 2024 | -72,000.00 |
| Jun 30, 2024 | -68,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Dec 31, 2023 | -66,000.00 |
| Sep 30, 2023 | -117,000.00 |
| Jun 30, 2023 | -72,000.00 |
| Mar 31, 2023 | -50,000.00 |